cached image

Parents

Sign in to add mentor
Johan Carel Koetsier grad student 1988 VU Amsterdam
 (Multiple Sclerosis and Experimental Allergic Encephalomyelitis: An Immunological Approach)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wiebenga OT, Schoonheim MM, Hulst HE, et al. (2016) White Matter Diffusion Changes during the First Year of Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis. Ajnr. American Journal of Neuroradiology
Wattjes MP, Wijburg MT, Vennegoor A, et al. (2015) MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS. Journal of Neurology, Neurosurgery, and Psychiatry
Wattjes MP, Rovira À, Miller D, et al. (2015) Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-establishing disease prognosis and monitoring patients. Nature Reviews. Neurology
Kappos L, O'Connor P, Radue EW, et al. (2015) Long-term effects of fingolimod in multiple sclerosis: the randomized FREEDOMS extension trial. Neurology. 84: 1582-91
Wiebenga OT, Klauser AM, Schoonheim MM, et al. (2015) Enhanced Axonal Metabolism during Early Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis. Ajnr. American Journal of Neuroradiology. 36: 1116-23
Vennegoor A, van Rossum JA, Polman CH, et al. (2015) Longitudinal JCV serology in multiple sclerosis patients preceding natalizumab-associated progressive multifocal leukoencephalopathy. Multiple Sclerosis (Houndmills, Basingstoke, England)
Gibbs E, Karim ME, Oger J, et al. (2015) Antibody dissociation rates are predictive of neutralizing antibody (NAb) course: a comparison of interferon beta-1b-treated Multiple Sclerosis (MS) patients with transient versus sustained NAbs. Clinical Immunology (Orlando, Fla.). 157: 91-101
Tewarie P, Schoonheim MM, Schouten DI, et al. (2015) Functional brain networks: linking thalamic atrophy to clinical disability in multiple sclerosis, a multimodal fMRI and MEG study. Human Brain Mapping. 36: 603-18
Vennegoor A, Rispens T, Van Oosten BW, et al. (2015) Application of serum natalizumab levels during plasma exchange in MS patients with progressive multifocal leukoencephalopathy. Multiple Sclerosis (Houndmills, Basingstoke, England). 21: 481-4
Bosma LV, Sonder JM, Kragt JJ, et al. (2015) Detecting clinically-relevant changes in progressive multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 21: 171-9
See more...